Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 43

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 43
---
 have no rights as a common stockholder until they acquire our common stock.

Until holders of the Warrants and the Pre-Funded
Warrants acquire shares of our common stock upon exercise of those warrants, the holders will have no rights with respect to the common
stock issuable upon exercise thereof. Upon exercise of those warrants, the holder will be entitled to exercise the rights of a common
stockholder as to the security exercised only as to matters for which the record date occurs after the exercise.

There is no public market for the Pre-Funded Warrants or Warrants being offered in this offering.

There is no established public trading market
for the Pre-Funded Warrants or Warrants being offered in this offering, and we do not expect a market to develop. In addition, we do not
intend to apply to list the Pre-Funded Warrants or the Warrants on any national securities exchange or other nationally recognized trading
system, including The Nasdaq Capital Market. Without an active trading market, the liquidity of the Pre-Funded Warrants and the Warrants
will be limited.

<div align='center'>19</div>

Since the Warrants and Pre-Funded Warrants are executory contracts, they may have no value in a bankruptcy or reorganization proceeding.

In the event a bankruptcy or reorganization proceeding
is commenced by or against us, a bankruptcy court may hold that any unexercised warrants are executory contracts that are subject to rejection
by us with the approval of the bankruptcy court. As a result, holders of the Warrants and Pre-Funded Warrants may, even if we have sufficient
funds, not be entitled to receive any consideration for their warrants or may receive an amount less than they would be entitled to if
they had exercised their warrants prior to the commencement of any such bankruptcy or reorganization proceeding.

Provisions of the Warrants offered by this prospectus could discourage an acquisition of us by a third-party.

Certain provisions of the Warrants offered by
this prospectus could make it more difficult or expensive for a third-party to acquire us. The Warrants prohibit us from engaging in certain
transactions constituting “fundamental transactions” unless, among other things, the surviving entity assumes our obligations
under the Warrants or we pay to the holders an amount in cash equal to the Black-Scholes Value (as defined in the Warrants). These and
other provisions of the Warrants offered by this prospectus could prevent or deter a third-party from acquiring us even where